ARTIVION, INC. (CRY) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues:
US	161.1	151.2	138.3
Surgical sealants	65.4	70.7	62.1
Aortic stent grafts	92.8	85.4	61.7
Non Us				125.7	118.2	54.6
Other				150.6	144.7	135.1
Total revenues [+]	313.8	298.8	253.2	276.2	262.8	189.7	180.4	145.9
Products								83.1
Services								62.8
Revenue growth [+]	5.0%	18.0%	-8.3%	5.1%	38.6%	5.2%	23.6%	0.9%
US	6.6%	9.3%
Surgical sealants	-7.5%	13.9%
Aortic stent grafts	8.6%	38.5%
Non Us				6.3%	116.5%
Preservation services	8.0%	4.5%					5.7%	0.1%
Cost of goods sold [+]	111.3	101.3	85.4	93.2	89.9	61.1	61.5	55.2
Cost of product sales								18.7
Cost of services								36.5
Gross profit	202.5	197.5	167.8	183.0	173.0	128.6	118.9	90.7
Gross margin	64.5%	66.1%	66.3%	66.3%	65.8%	67.8%	65.9%	62.2%
Selling, general and administrative	157.4	169.8	141.1	166.0	163.7	120.7	91.5	74.9
Research and development	38.9	35.5	24.2				13.4	10.4
Other operating expenses		-15.9		2.1	2.8	2.5	-7.9
EBITDA [+]	28.6	32.1	23.2	33.3	24.6	15.2	30.2	11.2
EBITDA growth	-10.8%	38.6%	-30.4%	35.4%	61.7%	-49.7%	169.3%	-24.5%
EBITDA margin	9.1%	10.7%	9.1%	12.0%	9.3%	8.0%	16.7%	7.7%
Depreciation	7.1	7.2	6.9	7.5	7.3	4.7	4.0	3.7
EBITA	21.5	24.9	16.2	25.8	17.3	10.5	26.2	7.5
EBITA margin	6.9%	8.3%	6.4%	9.3%	6.6%	5.6%	14.6%	5.1%
Amortization of intangibles	15.3	16.8	13.8	10.9	10.8	5.1	4.4	2.1
EBIT [+]	6.2	8.1	2.4	14.9	6.5	5.4	21.8	5.4
EBIT growth	-23.6%	232.5%	-83.7%	131.1%	18.7%	-75.0%	307.5%	-39.4%
EBIT margin	2.0%	2.7%	1.0%	5.4%	2.5%	2.9%	12.1%	3.7%
Interest expense, net [+]	18.1	16.8	16.5	12.6	14.8	2.3	3.0	0.0
Interest expense	18.2	16.9	16.7	13.3	15.0	2.6	3.0	0.1
Interest income	0.1	0.1	0.2	0.7	0.2	0.2	0.1	0.0
Other income (expense), net [+]	-3.1	-6.1	-3.1	-0.7	1.9	0.5	-0.4	0.5
Gain (loss) on sale of business		15.9					7.9
Realized gain (loss) on investments								-0.9
Other	-3.1	-6.1	-3.1		2.1	0.7	-0.4	-1.4
Pre-tax income	-15.0	-14.8	-17.2	1.6	-6.4	3.6	18.4	5.9
Income taxes	4.2	0.0	-0.5	-0.1	-3.6	-0.1	7.6	1.9
Tax rate			2.9%		55.6%		41.5%	31.7%
Net income	-19.2	-14.8	-16.7	1.7	-2.8	3.7	10.8	4.0
Net margin	-6.1%	-5.0%	-6.6%	0.6%	-1.1%	2.0%	6.0%	2.7%

Basic EPS [+]	($0.48)	($0.38)	($0.44)	$0.05	($0.08)	$0.11	$0.34	$0.14
Growth	26.0%	-13.6%	-1050.9%	-159.4%	-169.5%	-66.8%	134.4%	-46.0%
Diluted EPS [+]	($0.48)	($0.38)	($0.44)	$0.05	($0.08)	$0.11	$0.33	$0.14
Growth	26.0%	-13.6%	-1069.9%	-158.2%	-171.9%	-67.0%	134.0%	-45.7%

Dividends per share [+]								$0.12
Growth							-100.0%	1.7%

Shares outstanding (basic) [+]	40.0	39.0	37.9	37.1	36.4	33.0	31.9	27.7
Growth	2.7%	3.0%	2.0%	1.9%	10.3%	3.6%	14.8%	1.3%
Shares outstanding (diluted) [+]	40.0	39.0	37.9	37.9	36.4	34.2	32.8	28.5
Growth	2.7%	3.0%	0.0%	4.0%	6.6%	4.1%	15.0%	0.8%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.